The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have lost faith in its business model.
Category: Drugs (Pharmaceuticals)
-
UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.
The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have lost faith in its business model.
-
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
-
Heath Insurers Are Denying More Drug Claims, Data Shows
Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major private insurers.
-
Drugmakers Notch a $5 Billion Win in Republicans’ Policy Bill
More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings for the federal government.
-
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
-
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
-
What to Put in a Travel First-Aid Kit: Key Items to Include
Experts weigh in on what to bring for a healthy, stress-free trip.
-
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
-
Texas OK’s $50 Million for Ibogaine Research
The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.
-
Amanda Feilding, Countess Who Drilled a Hole in Her Head, Dies at 82
She was ridiculed for drilling a hole in her skull to increase blood flow, but her foundation’s research into the therapeutic use of counterculture drugs proved visionary.
-
F.D.A. Looks to A.I. to Enhance Efficiency
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.